A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Clinical trial NCT07124559 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07124559
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-15
- Primary completion
- 2028-01-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.